PhaseBio Pharmaceuticals, Inc. (PHAS)
Revenue Growth
-92.27%
TTM · Period ending:
PHAS Revenue Growth
Year-over-year change vs the same period a year earlier
Latest reported-92.27%period ending
Latest reported-92.27%period ending
PHAS TTM Revenue YoY % (351.09% → -92.27%)
Year-over-year change
High-resolution chart · PNG
PHAS revenue growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Revenue Growth |
|---|---|
| -92.2677% | |
| 1,059.7458% | |
| 756.8829% | |
| 426.2821% | |
| 421.6469% | |
| -53.4517% | |
| -46.4634% | |
| 9.3851% | |
| 0.1976% | |
| 53.5201% | |
| 253.4431% | |
| 351.0949% |